- USD/TRY adds to Tuesday’s gains well above 13.00.
- The lira loses further ground after a positive start of the year.
- Focus remains on the next CBRT event later in the month.
The Turkish lira accelerates losses and pushes USD/TRY to new 2-day highs in the 13.60 region midweek.
USD/TRY stronger after Turkey’s CPI
USD/TRY posts gains for the second day in a row on Wednesday, regaining upside traction and extending the bounce off Monday’s lows in the 12.70 region.
The lira resumed its downside in past sessions after cracks appeared in confidence following the government's announcement of a plan to reduce the dollarization of the economy and therefore promote savings in the domestic currency.
In the meantime, the effects of President Erdogan’s rescue plan continue to wear off and the impact on the lira is becoming more visible, particularly after inflation in the country rose above 36% in the year to December, the highest level in the last 19 years.
What to look for around TRY
The lira resumed its downtrend while market participants continued to digest the recent inflation figures and the government measures to promote the shift from dollars to the domestic currency. The reluctance of the CBRT to change the (collision?) course and the omnipresent political pressure to favour lower interest rates in the current context of rampant inflation are forecast to keep the lira under intense pressure. That said, another visit to the all-time high north of the 18.00 mark in USD/TRY should not be ruled out just yet.
Eminent issues on the back boiler: Progress (or lack of it) of the new scheme oriented to support the lira. Constant government pressure on the CBRT vs. bank’s credibility/independence. Bouts of geopolitical concerns. Much-needed structural reforms. Growth outlook vs. progress of the coronavirus pandemic. Potential assistance from the IMF in case another currency crisis re-emerges.
USD/TRY key levels
So far, the pair is gaining 1.36% at 13.5339 and a drop below 12.7523 (weekly low Jan.3) would pave the way for a test of 11.8128 (55-day SMA) and finally 10.2027 (monthly low Dec.23). On the other hand, the next up barrier lines up at 13.8967 (weekly high Jan.3) followed by 18.2582 (all-time high Dec.20) and then 19.0000 (round level).
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers. The author will not be held responsible for information that is found at the end of links posted on this page.
If not otherwise explicitly mentioned in the body of the article, at the time of writing, the author has no position in any stock mentioned in this article and no business relationship with any company mentioned. The author has not received compensation for writing this article, other than from FXStreet.
FXStreet and the author do not provide personalized recommendations. The author makes no representations as to the accuracy, completeness, or suitability of this information. FXStreet and the author will not be liable for any errors, omissions or any losses, injuries or damages arising from this information and its display or use. Errors and omissions excepted.
The author and FXStreet are not registered investment advisors and nothing in this article is intended to be investment advice.